{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:shahid-ghazi-pharmaceutical-company",
    "identifier": "hg:company:shahid-ghazi-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Shahid Ghazi Pharmaceutical Company",
    "slug": "shahid-ghazi-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/shahid-ghazi-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/shahid-ghazi-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/shahid-ghazi-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Shahid Ghazi Pharmaceutical Company Shahid Ghazi Pharmaceutical Company is a listed Tabriz-based manufacturer of sterile injectable and infusion products. In the Hormuz Group company graph, it matters because serum and sterile solutions are critical hospital inputs with direct links to healthcare resilience, pharmaceutical logistics, sterile manufacturing technology, public procurement, and supply-shortage risk. Its listed status makes it useful for monitoring hospital-demand pressure and the economics of strategic pharmaceutical staples. Shahid Ghazi Pharmaceutical is relevant for investors assessing Iran's sterile pharmaceutical manufacturing, infusion-solution supply, hospital procurement, critical medicine shortages, listed healthcare exposure, and export potential to neighboring markets. It can support analysis of capacity utilization, pricing regulation, sterile-production standards, energy and water reliability, packaging inputs, distributor receivables, and public-sector demand. Due diligence should review updated Codal disclosures, GMP compliance, production capacity, product mix, hospital and distributor contracts, export destinations, sterilization systems, water-for-injection infrastructure, ownership by pharmaceutical holdings, and sensitivity to raw-material or packaging constraints. Shahid Ghazi Pharmaceutical Company manufactures sterile injectable and irrigation pharmaceutical products for human and veterinary use, including infusion solutions, sterile washing solutions, injectable distilled water, saline and dextrose solutions, Ringer-type solutions, ophthalmic washing solutions, and related large-volume parenteral products. Its activity is linked to sterile production, hospital supply, serum demand, quality control, and critical healthcare logistics. province: East Azerbaijan industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer city: Tabriz",
    "published_at": "2026-06-28T20:28:56+00:00",
    "modified_at": "2026-06-28T20:28:56+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 8,
                "name": "East Azerbaijan",
                "slug": "east-azerbaijan",
                "url": "https://hormuz.group/provinces/east-azerbaijan/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            }
        ],
        "city": [
            {
                "id": 423,
                "name": "Tabriz",
                "slug": "tabriz",
                "url": "https://hormuz.group/cities/tabriz/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "East Azerbaijan",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer",
        "city": "Tabriz"
    },
    "fields_summary": {
        "legal_name": "Shahid Ghazi Pharmaceutical Company Public Joint Stock Company",
        "website": "https://sgco-infusion.com",
        "city": "Tabriz, East Azerbaijan Province, Iran",
        "ticker_symbol": "دقاضی",
        "listing_status": "listed_ifb",
        "products_services": "Shahid Ghazi Pharmaceutical Company manufactures sterile injectable and irrigation pharmaceutical products for human and veterinary use, including infusion solutions, sterile washing solutions, injectable distilled water, saline and dextrose solutions, Ringer-type solutions, ophthalmic washing solutions, and related large-volume parenteral products. Its activity is linked to sterile production, hospital supply, serum demand, quality control, and critical healthcare logistics.",
        "export_relevance": "medium",
        "short_profile": "Shahid Ghazi Pharmaceutical Company is a listed Tabriz-based manufacturer of sterile injectable and infusion products. In the Hormuz Group company graph, it matters because serum and sterile solutions are critical hospital inputs with direct links to healthcare resilience, pharmaceutical logistics, sterile manufacturing technology, public procurement, and supply-shortage risk. Its listed status makes it useful for monitoring hospital-demand pressure and the economics of strategic pharmaceutical staples.",
        "investment_relevance": "Shahid Ghazi Pharmaceutical is relevant for investors assessing Iran's sterile pharmaceutical manufacturing, infusion-solution supply, hospital procurement, critical medicine shortages, listed healthcare exposure, and export potential to neighboring markets. It can support analysis of capacity utilization, pricing regulation, sterile-production standards, energy and water reliability, packaging inputs, distributor receivables, and public-sector demand. Due diligence should review updated Codal disclosures, GMP compliance, production capacity, product mix, hospital and distributor contracts, export destinations, sterilization systems, water-for-injection infrastructure, ownership by pharmaceutical holdings, and sensitivity to raw-material or packaging constraints."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Shahid Ghazi Pharmaceutical Company Public Joint Stock Company",
        "city": "Tabriz, East Azerbaijan Province, Iran",
        "ticker_symbol": "دقاضی",
        "export_relevance": "medium",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "listed_ifb",
        "last_updated": "29/06/2026",
        "website": "https://sgco-infusion.com",
        "products_services": "Shahid Ghazi Pharmaceutical Company manufactures sterile injectable and irrigation pharmaceutical products for human and veterinary use, including infusion solutions, sterile washing solutions, injectable distilled water, saline and dextrose solutions, Ringer-type solutions, ophthalmic washing solutions, and related large-volume parenteral products. Its activity is linked to sterile production, hospital supply, serum demand, quality control, and critical healthcare logistics.",
        "short_profile": "Shahid Ghazi Pharmaceutical Company is a listed Tabriz-based manufacturer of sterile injectable and infusion products. In the Hormuz Group company graph, it matters because serum and sterile solutions are critical hospital inputs with direct links to healthcare resilience, pharmaceutical logistics, sterile manufacturing technology, public procurement, and supply-shortage risk. Its listed status makes it useful for monitoring hospital-demand pressure and the economics of strategic pharmaceutical staples.",
        "investment_relevance": "Shahid Ghazi Pharmaceutical is relevant for investors assessing Iran's sterile pharmaceutical manufacturing, infusion-solution supply, hospital procurement, critical medicine shortages, listed healthcare exposure, and export potential to neighboring markets. It can support analysis of capacity utilization, pricing regulation, sterile-production standards, energy and water reliability, packaging inputs, distributor receivables, and public-sector demand. Due diligence should review updated Codal disclosures, GMP compliance, production capacity, product mix, hospital and distributor contracts, export destinations, sterilization systems, water-for-injection infrastructure, ownership by pharmaceutical holdings, and sensitivity to raw-material or packaging constraints.",
        "source_note": "Based on public company, official-company, pharmaceutical-sector, infusion-product, sterile-manufacturing, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 62
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 38
        },
        "ticker_symbol": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 25
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 480
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 508
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 773
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 249
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, official-company, pharmaceutical-sector, infusion-product, sterile-manufacturing, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026"
    }
}